127 related articles for article (PubMed ID: 37777411)
21. Therapeutic potential of targeting
Tang X; Luo L; Li Y; Wu H; Hu Q; Yue H; He X; Zou J; Min S
Aging (Albany NY); 2020 Dec; 13(1):1212-1235. PubMed ID: 33291071
[TBL] [Abstract][Full Text] [Related]
22. Prognostic impact of adenomatous polyposis coli gene expression in osteosarcoma of the extremities.
Guimarães AP; Rocha RM; da Cunha IW; Guimarães GC; Carvalho AL; de Camargo B; Lopes A; Squire JA; Soares FA
Eur J Cancer; 2010 Dec; 46(18):3307-15. PubMed ID: 20594821
[TBL] [Abstract][Full Text] [Related]
23. A novel alternative splicing-related prognostic signature for osteosarcoma.
Zhang J; Liang J; Chang X; Ge R
Asian J Surg; 2023 Dec; 46(12):5882-5884. PubMed ID: 37659943
[No Abstract] [Full Text] [Related]
24. Comment on Xu XW et al.: Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis.
He S; Xiao Z; Chen L; Xiong S
Tumour Biol; 2014 Jul; 35(7):6193-4. PubMed ID: 24852425
[No Abstract] [Full Text] [Related]
25. Matrix metalloproteinase 2 expression and survival of patients with osteosarcoma: a meta-analysis.
Wen X; Liu H; Yu K; Liu Y
Tumour Biol; 2014 Jan; 35(1):845-8. PubMed ID: 24037915
[TBL] [Abstract][Full Text] [Related]
26. Comment on Lun et al. entitled "The prognostic value of elevated ezrin in patients with osteosarcoma".
Li Z; Li Y
Tumour Biol; 2014 May; 35(5):5051. PubMed ID: 24390666
[No Abstract] [Full Text] [Related]
27. An Immunohistochemical Study of Stathmin 1 Expression in Osteosarcoma Shows an Association with Metastases and Poor Patient Prognosis.
Zhao C; Li H; Wang L; Sun W
Med Sci Monit; 2018 Aug; 24():6070-6078. PubMed ID: 30169496
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of VEGF expression in osteosarcoma: a meta-analysis.
Yu XW; Wu TY; Yi X; Ren WP; Zhou ZB; Sun YQ; Zhang CQ
Tumour Biol; 2014 Jan; 35(1):155-60. PubMed ID: 23907576
[TBL] [Abstract][Full Text] [Related]
29. Expression profiles of osteosarcoma that can predict response to chemotherapy.
Man TK; Chintagumpala M; Visvanathan J; Shen J; Perlaky L; Hicks J; Johnson M; Davino N; Murray J; Helman L; Meyer W; Triche T; Wong KK; Lau CC
Cancer Res; 2005 Sep; 65(18):8142-50. PubMed ID: 16166288
[TBL] [Abstract][Full Text] [Related]
30. A novel prognostic signature in osteosarcoma characterised from the perspective of unfolded protein response.
Shi C; Zhao F; Zhang T; Xu D; Hao Z; Cui F; Shi JH; Jin Y; Li N; Yang C; Zhang Y; Sheng X
Clin Transl Med; 2022 Mar; 12(3):e750. PubMed ID: 35343090
[No Abstract] [Full Text] [Related]
31. Molecular classification of osteosarcoma.
Lau CC
Cancer Treat Res; 2009; 152():459-65. PubMed ID: 20213408
[TBL] [Abstract][Full Text] [Related]
32. Identification of mitochondrial-related signature and molecular subtype for the prognosis of osteosarcoma.
Zhao X; Zhang J; Liu J; Chen Q; Cai C; Miao X; Wu T; Cheng X
Aging (Albany NY); 2023 Nov; 15(22):12794-12816. PubMed ID: 37976137
[TBL] [Abstract][Full Text] [Related]
33. Genomic alterations and allelic imbalances are strong prognostic predictors in osteosarcoma.
Smida J; Baumhoer D; Rosemann M; Walch A; Bielack S; Poremba C; Remberger K; Korsching E; Scheurlen W; Dierkes C; Burdach S; Jundt G; Atkinson MJ; Nathrath M
Clin Cancer Res; 2010 Aug; 16(16):4256-67. PubMed ID: 20610556
[TBL] [Abstract][Full Text] [Related]
34. Identification of 9-Gene Epithelial-Mesenchymal Transition Related Signature of Osteosarcoma by Integrating Multi Cohorts.
Yiqi Z; Ziyun L; Qin F; Xingli W; Liyu Y
Technol Cancer Res Treat; 2020; 19():1533033820980769. PubMed ID: 33308057
[TBL] [Abstract][Full Text] [Related]
35. Familial osteogenic sarcoma.
Swaney JJ
Clin Orthop Relat Res; 1973; (97):64-8. PubMed ID: 4521231
[No Abstract] [Full Text] [Related]
36. Retinoblastoma and osteosarcoma: the prototypic cancer family.
Hansen MF; Cavenee WK
Acta Paediatr Jpn; 1987 Aug; 29(4):526-33. PubMed ID: 3144887
[No Abstract] [Full Text] [Related]
37. Prognostic value of the microRNA-29 family in patients with primary osteosarcomas.
Hong Q; Fang J; Pang Y; Zheng J
Med Oncol; 2014 Aug; 31(8):37. PubMed ID: 25015394
[TBL] [Abstract][Full Text] [Related]
38. Prognostic value of CCN3 in osteosarcoma.
Perbal B; Zuntini M; Zambelli D; Serra M; Sciandra M; Cantiani L; Lucarelli E; Picci P; Scotlandi K
Clin Cancer Res; 2008 Feb; 14(3):701-9. PubMed ID: 18245529
[TBL] [Abstract][Full Text] [Related]
39. [Characterization of Cell Subsets Associated With Prognosis of Osteosarcoma Based on Single-Cell Sequencing Data].
Wang ST; Zhu HR; Xu SJ; Gui P; Chen MZ; Li ZX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Oct; 45(5):773-782. PubMed ID: 37927019
[TBL] [Abstract][Full Text] [Related]
40. High levels of long non-coding RNA DICER1-AS1 are associated with poor clinical prognosis in patients with osteosarcoma.
Hu XH; Dai J; Shang HL; Zhao ZX; Hao YD
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7640-7645. PubMed ID: 30536305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]